EZH2 catalyzes tri-methylation of histone H3 at Lys27 (H3K27me3) and has a role in epigenetic activation and silencing of key oncogenes and tumor suppressor genes in multiple cancers as well as contributing to drug resistance (75). The gene discussed is EZH2; the disease is neoplasm.